Cerebral toxoplasmosis after rituximab therapy

JAMA Internal Medicine

Volumn 173, Issue 10, 2013, Pages 924-926

  Safa, Gilles ^a   Darrieux, Laure ^a  

^a Department of Dermatology Centre Hospitalier de Saint Brieuc   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; FOLINIC ACID; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METHYLPREDNISOLONE; PREDNISONE; PYRIMETHAMINE; RITUXIMAB; SULFADIAZINE;

AGED; ARTICLE; BEHAVIOR CHANGE; BRADYZOITE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; LEG ULCER; NECROTIZING ARTERITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY; SPEECH DISORDER; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREATMENT OUTCOME; ULCER HEALING; WEIGHT REDUCTION;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; MAGNETIC RESONANCE IMAGING; NECROSIS; POLYMERASE CHAIN REACTION; SKIN DISEASES; TOXOPLASMA; TOXOPLASMOSIS, CEREBRAL; VASCULITIS;

EID: 84878511774     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.374     Document Type: Article

References (10)

1. Gürcan HM, Keskin DB, Stern JN, Nitzberg MA, Shekhani H, Ahmed AR. A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol. 2009;9(1):10-25.
2. Kelesidis T, Daikos G, Boumpas D, Tsiodras S. Does rituximab increase the incidence of infectious complications? a narrative review. Int J Infect Dis. 2011;15(1):e2-e16.
3. Montoya JG, LiesenfeldO. Toxoplasmosis. Lancet. 2004;363(9425):1965-1976. (Pubitemid 38759657)
4. Derouin F, Pelloux H; ESCMID Study Group on Clinical Parasitology. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect. 2008;14(12):1089-1101.
5. Eisenberg R. Update on rituximab. Ann Rheum Dis. 2005;64(suppl 4):iv55-iv57. (Pubitemid 41532020)
6. Gottenberg JE, Ravaud P, Bardin T, et al. Low serum IgG level after rituximab is associated with an increased risk of serious infections in rheumatoid arthritis: data of the AIR registry: Abstracts of the American College of Rheumatology and Association of Rheumatology Health Professionals Annual Scientific Meeting; November 4-9, 2011; Chicago, Illinois. Arthritis Rheum. 2011;63(suppl 10):S641-S642.
7. Amezcua Vesely MC, Bermejo DA, Montes CL, Acosta-Rodríguez EV, Gruppi A. B-cell response during protozoan parasite infections. J Parasitol Res. 2012;2012:362131.
8. Meersseman W, Lagrou K, Sciot R, et al. Rapidly fatal Acanthamoeba encephalitis and treatment of cryoglobulinemia. Emerg Infect Dis. 2007;13(3):469-471. (Pubitemid 46348145)
9. Krause PJ, Gewurz BE, Hill D, et al. Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis. 2008;46(3):370-376. (Pubitemid 351263520)
10. Furst DE. Serum immunoglobulins and risk of infection: how low can you go? Semin Arthritis Rheum. 2009;39(1):18-29.